Home
Contact Us
SUBSCRIBE
RESOURCES
Search


SPECIAL FOCUS REPORT
PDMA 2010: The Power of Sharing
The PDMA Alliance is celebrating its 20th anniversary at this year's annual meeting, to be held in San Diego on Oct. 3-6. Here's what attendees can expect to learn and experience at the meeting.
print the article
send to a friend
LATEST NEWS
‘On-dosage’ authentication gets a boost with Capsugel-NanoGuardian partnership
   Date: 2010-02-22


Capsugel will provide nano-encryption for capsules through technology license



Pharma service providers and contract manufacturing organizations continue to create new options for drugmakers seeking to protect their products against counterfeiting. While most of these techniques apply to packaging and labels, there seems to be a trend developing in “on dosage” techniques applied directly to tablets or capsules.

The latest: Capsugel (Peapack, NJ), a division of Pifzer, has announced a licensing agreement with NanoGuardian (Skokie, IL) to employ the latter’s nanoscale marking technology on capsules. Nanoguardian has been promoting this technology for the past couple years as a means of not only putting overt (but hard to duplicate) markings on tablets, but also covert identification data, such as a lot number, within the overt marking. There are no additional materials, such as taggants, added to the marking, and the company claims that the technology costs less than a penny per pill.

Capsugel is the first company to apply this level of authentication to capsules, according to a company spokesperson. “We will provide the encoded capsules, then manufacturers will use them in their own filling operations,” says Alyssa Augustine, director of communications at Capsugel. The company is in the process of acquiring an encryption machine that will be added to one of its production lines, and clients can order batches of encoded capsules, in lot sizes up to one million, with each lot having a unique marking. Production is expected to be ready by the middle of this year.

Last summer, Colorcon (Harleyville, PA), a leading provider of coatings and excipients for tablets, announced a similar partnering with ARmark Technologies (Glen Rock, PA), which has developed nano-scale microtaggants that can be added to the coatings that Colorcon sells; ARmark calls the technology On-Dose ID. This announcement came right after FDA issued draft guidance on “physical-chemical identifiers” (PCIDs), generally allowing their use as long as the PCIDs are inert.

Colorcon has a Brand Enhancement Service that includes using specialized pigments as counterfeit-resistant measures; even adding barcodes to a tablet surface. Similarly, Merck KGaA (Darmstadt, Germany) has been promoting its Candurin coatings with the same capability.

Registered user? Log-In here

CURRENT ISSUE

Home
Contact Us
SUBSCRIBE
RESOURCES
Search
RSS
Pharmaceutical Commerce © 2010 Developed byMushoq